Crossmark

CA724 predicts overall survival in locally advanced gastric cancer patients with neoadjuvant chemotherapy

Published Online: 2021-01-05

Published Print: 2021-12

Authors

Tong, Yilin

Zhao, Yan

Shan, Zexing

Zhang, Jianjun http://orcid.org/0000-0001-6672-2469
License Information

Text and Data Mining valid from 2021-01-05

Version of Record valid from 2021-01-05
More Information

Article History

Received: 11 November 2019

Accepted: 19 November 2020

First Online: 5 January 2021

Ethics approval and consent to participate

: The study was reviewed and approved by the Faculty of Science Ethics Committee at Liaoning Cancer Hospital and Institute (Cancer Hospital of China Medical University). This is a retrospective study and all patients have signed the informed consent prior to treatment.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current